123 related articles for article (PubMed ID: 36827074)
1. Expression of AKRs superfamily and prognostic in human gastric cancer.
Zhou Y; Lin Y; Li W; Liu Q; Gong H; Li Y; Luo D
Medicine (Baltimore); 2023 Feb; 102(8):e33041. PubMed ID: 36827074
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
Ebert B; Kisiela M; Wsól V; Maser E
Chem Biol Interact; 2011 May; 191(1-3):239-49. PubMed ID: 21215737
[TBL] [Abstract][Full Text] [Related]
3. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
[TBL] [Abstract][Full Text] [Related]
4. The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients.
Hlaváč V; Brynychová V; Václavíková R; Ehrlichová M; Vrána D; Pecha V; Trnková M; Kodet R; Mrhalová M; Kubáčková K; Gatěk J; Vážan P; Souček P
Medicine (Baltimore); 2014 Dec; 93(28):e255. PubMed ID: 25526449
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine.
Hirosawa K; Fujioka H; Morinaga G; Fukami T; Ishiguro N; Kishimoto W; Nakase H; Mizuguchi H; Nakajima M
Drug Metab Dispos; 2023 Dec; 51(12):1569-1577. PubMed ID: 37722844
[TBL] [Abstract][Full Text] [Related]
6. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer.
Hojnik M; Šuster NK; Smrkolj Š; Sisinger D; Grazio SF; Verdenik I; Rižner TL
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159076
[TBL] [Abstract][Full Text] [Related]
7. The Expression and Clinical Significance of Aldo-Keto Reductase 1 Member B1 in Gastric Carcinoma.
Li X; Yang J; Gu X; Xu J; Li H; Qian J; Chen L
DNA Cell Biol; 2020 Jul; 39(7):1322-1327. PubMed ID: 32412859
[TBL] [Abstract][Full Text] [Related]
8. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
Taskoparan B; Seza EG; Demirkol S; Tuncer S; Stefek M; Gure AO; Banerjee S
Cell Oncol (Dordr); 2017 Dec; 40(6):563-578. PubMed ID: 28929377
[TBL] [Abstract][Full Text] [Related]
9. AKR1B10, a good prognostic indicator in gastric cancer.
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis Reveals the Vital Role of AKR1B1 in Immune Infiltration and Clinical Outcomes of Gastric Cancer.
Zhao Z; Hao Z; Zhang Z; Zhan X
DNA Cell Biol; 2023 Jul; 42(7):372-389. PubMed ID: 37285280
[TBL] [Abstract][Full Text] [Related]
11. Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition.
Liu M; Qin X; Li J; Jiang Y; Jiang J; Guo J; Xu H; Wang Y; Bi H; Wang Z
Phys Chem Chem Phys; 2024 Mar; 26(12):9295-9308. PubMed ID: 38469695
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human livers.
Amai K; Fukami T; Ichida H; Watanabe A; Nakano M; Watanabe K; Nakajima M
Drug Metab Pharmacokinet; 2020 Dec; 35(6):539-547. PubMed ID: 33036882
[TBL] [Abstract][Full Text] [Related]
13. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
14. AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition.
Shao X; Wu J; Yu S; Zhou Y; Zhou C
Aging (Albany NY); 2021 Sep; 13(18):22298-22314. PubMed ID: 34552036
[TBL] [Abstract][Full Text] [Related]
15. AKR1B10 regulates M2 macrophage polarization to promote the malignant phenotype of gastric cancer.
Wu Y; Hao Y; Zhuang Q; Ma X; Shi C
Biosci Rep; 2023 Oct; 43(10):. PubMed ID: 37039038
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer.
Saeed A; Ejaz SA; Sarfraz M; Tamam N; Siddique F; Riaz N; Qais FA; Chtita S; Iqbal J
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807227
[TBL] [Abstract][Full Text] [Related]
17. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas.
Hojnik M; Frković Grazio S; Verdenik I; Rižner TL
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298614
[TBL] [Abstract][Full Text] [Related]
18. Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks.
Banerjee S
Adv Exp Med Biol; 2021; 1347():65-82. PubMed ID: 33945128
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
Zhang L; Zhang H; Zhao Y; Li Z; Chen S; Zhai J; Chen Y; Xie W; Wang Z; Li Q; Zheng X; Hu X
FEBS Lett; 2013 Nov; 587(22):3681-6. PubMed ID: 24100137
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10.
Morikawa Y; Kezuka C; Endo S; Ikari A; Soda M; Yamamura K; Toyooka N; El-Kabbani O; Hara A; Matsunaga T
Chem Biol Interact; 2015 Mar; 230():30-9. PubMed ID: 25686905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
